GSK3B and chronic myelogenous leukemia, BCR-ABL1 positive: IM has been shown to inhibit Wnt signalling in CML cells [55] and in the murine myeloid progenitor cell line 32Dcl3 [56] in a way that may involve inhibition of Dishevelled and activation of GSK3β, both of which are key players in the canonical Wnt signalling pathway.